Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
4Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
Omeros Corporation (OMER) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
2Distinct source URLs
7High confidence
0.818Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Omeros Corporation Suppliers
Ticker
Name
Confidence
Evidence
LONZA-BIOLOGICS-TUAS-PTE-LTD
LONZA-BIOLOGICS-TUAS-PTE-LTD
92%
In July 2019, we entered into a master services agreement with Lonza Biologics Tuas Pte. Ltd. ("Lonza") for the commercial production of YARTEMLEA
NOVO-NORDISK
NOVO-NORDISK
90%
Under the Transition Services Agreement, we are transitioning to Novo Nordisk certain agreements and relationships with third parties that manufacture, store, and distribute zaltenibart for use in pr…
Omeros Corporation Customers
Ticker
Name
Confidence
Evidence
NOVO-NORDISK
NOVO-NORDISK
90%
The APLA with Novo Nordisk includes variable consideration in the form of milestone payments that are contingent upon the achievement of specified development, regulatory or commercialization events
COMPUTERSHARE-TRUST-COMPANY
COMPUTERSHARE-TRUST-COMPANY
62%
ith Conversion and Other Options (Subtopic 470-20), Induced Conversions of Convertible Debt Instruments , which clarifies the requirements for determining whether certain settlements of convertible d…
HIGHBRIDGE-CAPITAL-MANAGEMENT-LLC
HIGHBRIDGE-CAPITAL-MANAGEMENT-LLC
62%
Item 8, “Note 9 – OMIDRIA Royalty Obligation” to our Consolidated Financial Statements in this Annual Report on Form 10-K for additional information. Debt Financing Transactions Repayment at Maturity…
RAYNER-SURGICAL-INC
RAYNER-SURGICAL-INC
62%
set Sale Transactions The Company evaluates transactions involving the sale of our compounds, products or drug programs to determine whether such arrangements represent a sale of a business or a sale…
Omeros Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
OMER-DEBT-11516
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
OMER-DEBT
Debt stack $134.3M
90%
Market cache reports total debt of $134.3M.
OMER-DEBT-11515
Warrants outstanding: 200000
90%
xbrl warrant detail from xbrl 2023-04-12.
Omeros Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Omeros Corporation.
Omeros Corporation Ownership
Holder
Name
Confidence
Evidence
OMER-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 162 tracked holders.
Omeros Corporation Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
